While evidence is still emerging, this strategy may reduce the impact on gut motility and improve prep outcomes
On the other hand, there are no data to indicate that long-term, 'controlled' use of illicit drugs directly affects the risk or benefit of HCV treatment, which therefore should be considered based on the HCV genotype, stage of the disease, and other factors, as in persons not using illicit drugs
Some may last longer, others shorter
Possible Chiari malformation or increased intracranial pressure
NSL literature pointer PMID 10911661 L-Carnitine laboratory index [PMID: 10911661] National Science Labs indexing note for PMID 10911661: review the PubMed methods, models, and limitations before citing
What else might be impacted